Introduction: The opinion of experts (different specialties) on the triple fixed-dose antihypertensive therapy in clinical practice may differ.
Materials and methods: Online questionnaire with controversial aspects of the triple therapy answered by panel of experts in hypertension (HT) using two-round modified Delphi method.
Results: The questionnaire was completed by 158 experts: Internal Medicine (49), Nephrology (26), Cardiology (83). Consensus was reached (agreement) on 27/45 items (60%); 7 items showed differences statistically significant. Consensus was reached regarding: Predictive factors in the need for combination therapy and its efficacy vs. increasing the dose of a pretreatment, and advantage of triple therapy (prescription/adherence/cost/pressure control) vs. free combination.
Conclusions: This consensus provides an overview of the clinical use of triple therapy in moderate-severe and resistant/difficult to control HT.
Keywords: Antihipertensivos; Antihypertensive drugs; Arterial hypertension; Combinación de medicamentos; Drug combination; Hipertensión arterial.
Copyright © 2016 SEH-LELHA. Publicado por Elsevier España, S.L.U. All rights reserved.